JNJ-1013

Cat. No. M41291

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.

JNJ-1013 is a potent and selective IRAK1 degrader with an IC50s of 72, 443, 1071 nM for IRAK1, IRAK4, VHL FP respectively.

Molecular Weight	878.05
Formula	C46H55N9O7S
CAS Number	2597343-08-1
Form	Solid
Solubility (25°C)	DMSO 20 mg/mL (ultrasonic and warming)
Storage	4°C, protect from light

Related IRAK Products
CA-4948 CA-4948 is a selective, potent and orally active inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) that regulates IRAK4 function in the TLR and IL-1R signaling cascades. CA-4948 has good pharmacokinetic characteristics and antitumor activity in vitro and in vivo.
AS 2444697 AS 2444697 is a potent and selective IRAK4 inhibitor.
Zimlovisertib PF06650833 (Zimlovisertib) is an inhibitor of Interleukin-1 receptor associated kinase 4 (IRAK4).
IRAK-1-4 Inhibitor I IRAK-1-4 Inhibitor I is an inhibitor of interleukin-1 receptor-associated kinase 1/4 (IRAK 1/4) with IC50s of 0.3 μM and 0.2 μM, respectively.
Zabedosertib Zabedosertib (BAY 1834845) is a selective, orally potent IRAK4 inhibitor with immunomodulatory and anti-inflammatory activity and an IC50 value of 3.55 nM. Zabedosertib (BAY 1834845) exhibits anti-inflammatory property against IL-β, LPS and Imiquimod induced inflammation.

Catalog